Independent Anatomic Pathology Ltd - Period Ending 2023-04-30

Independent Anatomic Pathology Ltd - Period Ending 2023-04-30


Independent Anatomic Pathology Ltd 13323112 false 2022-05-01 2023-04-30 2023-04-30 The principal activity of the company is veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true 13323112 2022-05-01 2023-04-30 13323112 2023-04-30 13323112 core:RetainedEarningsAccumulatedLosses 2023-04-30 13323112 core:ShareCapital 2023-04-30 13323112 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-30 13323112 bus:SmallEntities 2022-05-01 2023-04-30 13323112 bus:AuditExemptWithAccountantsReport 2022-05-01 2023-04-30 13323112 bus:FullAccounts 2022-05-01 2023-04-30 13323112 bus:SmallCompaniesRegimeForAccounts 2022-05-01 2023-04-30 13323112 bus:RegisteredOffice 2022-05-01 2023-04-30 13323112 bus:Director1 2022-05-01 2023-04-30 13323112 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 13323112 core:OfficeEquipment 2022-05-01 2023-04-30 13323112 core:PlantMachinery 2022-05-01 2023-04-30 13323112 countries:AllCountries 2022-05-01 2023-04-30 13323112 2022-04-30 13323112 2021-04-08 2022-04-30 13323112 2022-04-30 13323112 core:RetainedEarningsAccumulatedLosses 2022-04-30 13323112 core:ShareCapital 2022-04-30 13323112 core:CurrentFinancialInstruments core:WithinOneYear 2022-04-30 iso4217:GBP xbrli:pure

Registration number: 13323112

Independent Anatomic Pathology Ltd

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 April 2023

 

Independent Anatomic Pathology Ltd

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 4

 

Independent Anatomic Pathology Ltd

(Registration number: 13323112)
Abridged Balance Sheet as at 30 April 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

5,124

6,582

Current assets

 

Debtors

7,202

12,264

Cash at bank and in hand

 

108,880

66,618

 

116,082

78,882

Creditors: Amounts falling due within one year

(81,068)

(52,684)

Net current assets

 

35,014

26,198

Total assets less current liabilities

 

40,138

32,780

Provisions for liabilities

(1,172)

(1,444)

Net assets

 

38,966

31,336

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

38,866

31,236

Total equity

 

38,966

31,336

 

Independent Anatomic Pathology Ltd

(Registration number: 13323112)
Abridged Balance Sheet as at 30 April 2023

For the financial year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 16 October 2023
 

Mr S R Beck

Director

 

Independent Anatomic Pathology Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2023

1

General information

The company is a private company limited by share capital, incorporated in England & Wales .

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the director on 16 October 2023.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

 

Independent Anatomic Pathology Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2023

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and Machinery

25% Straight Line Method

Office Equipment

25% Straight Line Method

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2022 - 2).

4

Tangible assets

Total
£

Cost or valuation

At 1 May 2022

8,776

Additions

982

At 30 April 2023

9,758

Depreciation

At 1 May 2022

2,194

Charge for the year

2,440

At 30 April 2023

4,634

Carrying amount

At 30 April 2023

5,124

At 30 April 2022

6,582